Finds improved VO2 max in severe eosinophilic CRSwNP with anti-IL-5 therapy, suggesting potential cardiovascular benefits.
Chronic rhinosinusitis with nasal polyps (CRSwNP) and asthma frequently coexist [1], driven by type 2 inflammation involving eosinophils, interleukin-5 (IL-5), and systemic immune activation [2,3]....
No takes yet. Share an insight, caveat, or question.
Tidemandsen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: